SpeeDx | EntericPlex
SpeeDx has developed several concise EntericPlex panels that target common parasitic or bacterial pathogens that cause gastroenteritis.
SpeeDx | Technology
Class-leading PlexPCR® is the engine driving the entire SpeeDx product range, utilising two proprietary technologies: PlexZyme® and PlexPrime®.
SpeeDx | PlexPCR® VHS Documentation
Patented technology drives molecular diagnostics for detection of viral and bacterial infections and antibiotic resistance markers.
About SpeeDx Pty Ltd Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic …
SpeeDx | Technology
PlexZyme® is a patented detection technology allowing reliable multiplexing in qPCR testing without loss of sensitivity.
SpeeDx | ResistancePlus® MG FleXible | Documentation
Combined test for detection of Mycoplasma genitalium and macrolide antibiotic resistance biomarkers from swab or urine specimens.
Media Room - SpeeDx
SpeeDx library of symposia and presentations from key satellite events and stay up to date with the latest applications of infectious disease diagnostics.
SpeeDx Expand US Operations with New Laboratory Facility - SpeeDx
Aug 5, 2021 · SpeeDx announced the expansion of US based operations and will initiate construction of clinical testing facilities in Austin, Texas.
About SpeeDx Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specialises in molecular diagnostic solutions …
SpeeDx Analysis ResistancePlus® MG ample processing. Supporting rapid, routine diagnostics with quality control, searchable databases, audit-trail, and ser traceability. High security and GDPR …